Stock listing
Pharmacyte Biotech, Inc.
Selected listing: PMCB · NASDAQ · USD · US
Pharmacyte Biotech, Inc. (NASDAQ:PMCB), Health Technology. Latest release Nov 25, 2025: PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening…
- Ticker
- NASDAQ:PMCB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NASDAQ
- Currency
- USD
About Pharmacyte Biotech, Inc.
Pharmacyte Biotech, Inc. is a public company traded under the ticker PMCB in the American market. Pharmacyte focuses on developing innovative therapies for cancer and other serious diseases.
Latest news from Pharmacyte Biotech, Inc.
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
November 25, 2025
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
September 1, 2025
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
August 20, 2025
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
August 18, 2025
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
May 20, 2024
Research Pharmacyte Biotech, Inc.
Pharmacyte Biotech, Inc. company profile
View the public company page for Pharmacyte Biotech, Inc. on 6ix.
Pharmacyte Biotech, Inc. news
Read company news and market updates connected to Pharmacyte Biotech, Inc..
Pharmacyte Biotech, Inc. investor events
Find investor webinars, events, and replay context for Pharmacyte Biotech, Inc..